Skip to main content

Table 1 Baseline characteristics of all the children in the study

From: Tocotrienol-rich fractions (TRF) supplementation in school-going children with Attention Deficit/Hyperactive Disorder (ADHD): a randomized controlled trial

  Placebo n = 73 TRF n = 73 p value
Age in years (mean, SD) 9.4 (1.7) 9.4 (1.9) 0.854
Male: Female ratio 61 male: 12 female 63 male: 10 female 0.644
Education Type (n)    
 Mainstream 58 56 0.689
 Special education 13 15  
 Others 2 2  
Parental Education (n)    
 None/Primary 7 9 0.866
 Secondary 46 45  
 Tertiary 20 19  
ADHD subtypes (n)    
 Inattentive 9 8 0.796
 Combined 64 65  
Presence of comorbid conditions (n) 30 26 0.496
Medication for ADHD (n) 35 43 0.184
Mean Baseline VAPRS total symptom score (SD) 28.97 (9.37) 28.91 (10.37) 0.976
Mean Baseline VATRS total symptom score (SD)a 25.83 (10.35)a 25.40 (10.55)a 0.844
Baseline tocotrienol levels (Median)    
 Delta (ng/ml) 9.900 10.050 0.967
 Gamma (ng/ml) 43.30 48.40 0.709
 Alpha (ng/ml) 24.60 26.40 0.935
  1. aOnly 95 VATRS were returned (53 from placebo group, 42 from TRF group)